Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
To the Editor We commend Comes et al 1 for recognizing the challenges of conducting randomized trials. They reported longterm follow-up while assessing a "restrictive" approach for symptomatic cholelithiasis on postoperative pain, 2 concluding that cholecystectomy can be safely avoided. However, we do have some concerns.It cannot be understated that 70% or more of the patients in both arms required cholecystectomy at 6 weeks, highlighting that symptomatic cholelithiasis remains a surgical disease and most patients require short-interval elective cholecystectomy.The primary outcome was a pain scale developed for chronic pain in chronic pancreatitis. It might be argued that reported pain rates are not valid, and most patients were satisfied with their care, likely a more important measure. Furthermore, common conditions that might account for persistent pain (eg, inflammatory bowel disease, irritable bowel syndrome, endometriosis) were not considered. With 80% receiving cholecystectomy, and nearly 80% achieving a pain score of 4 points or lower on a visual analog scale, surgical management seems to achieve excellent outcomes.Both arms reported similar surgical and biliary complications. However, it might equally be concluded that the operative approach introduced no greater risk. Moreover, there were a surprising number of surgically preventable biliary complications (cholecystitis, choledocholithiasis) in the standard cohort. 3 Subanalysis among operative patients was not reported, so the causes cannot be assessed.Watchful waiting may beget additional costly testing in an already-strained US health care system, whereas cholecystectomy is exceedingly safe and relatively inexpensive. 4 The follow-up cost-effectiveness analysis noted marginal cost savings. 5 However, this ignores potential immortal-time bias variant, where the additional workup encouraged in restrictive pathway occurred during an unreported preoperative period. The standard approach simply involved cholecystectomy, we suspect without additional workup. We welcome clarification if additional data are available.Finally, the authors did not consider health disparities. Access to elective surgical care remains a significant challenge for socially vulnerable communities in the US. Recommending that more than 60% have additional testing, consulta-
To the Editor We commend Comes et al 1 for recognizing the challenges of conducting randomized trials. They reported longterm follow-up while assessing a "restrictive" approach for symptomatic cholelithiasis on postoperative pain, 2 concluding that cholecystectomy can be safely avoided. However, we do have some concerns.It cannot be understated that 70% or more of the patients in both arms required cholecystectomy at 6 weeks, highlighting that symptomatic cholelithiasis remains a surgical disease and most patients require short-interval elective cholecystectomy.The primary outcome was a pain scale developed for chronic pain in chronic pancreatitis. It might be argued that reported pain rates are not valid, and most patients were satisfied with their care, likely a more important measure. Furthermore, common conditions that might account for persistent pain (eg, inflammatory bowel disease, irritable bowel syndrome, endometriosis) were not considered. With 80% receiving cholecystectomy, and nearly 80% achieving a pain score of 4 points or lower on a visual analog scale, surgical management seems to achieve excellent outcomes.Both arms reported similar surgical and biliary complications. However, it might equally be concluded that the operative approach introduced no greater risk. Moreover, there were a surprising number of surgically preventable biliary complications (cholecystitis, choledocholithiasis) in the standard cohort. 3 Subanalysis among operative patients was not reported, so the causes cannot be assessed.Watchful waiting may beget additional costly testing in an already-strained US health care system, whereas cholecystectomy is exceedingly safe and relatively inexpensive. 4 The follow-up cost-effectiveness analysis noted marginal cost savings. 5 However, this ignores potential immortal-time bias variant, where the additional workup encouraged in restrictive pathway occurred during an unreported preoperative period. The standard approach simply involved cholecystectomy, we suspect without additional workup. We welcome clarification if additional data are available.Finally, the authors did not consider health disparities. Access to elective surgical care remains a significant challenge for socially vulnerable communities in the US. Recommending that more than 60% have additional testing, consulta-
COMMENT & RESPONSEIn Reply We thank Wehrle and colleagues for their comments and advocacy that routine cholecystectomy for gallstone disease should remain the standard of care, with nonoperative management being the exception. The conclusion from the long-term follow-up of the SECURE trial was that the restrictive strategy is as disappointing as usual care in achieving a pain-free state after cholecystectomy. 1 Additionally, treatment satisfaction and the rate of biliary and surgical complications between usual care and the restrictive strategy showed no significant difference. These results should not be interpreted as a reason to abandon cholecystectomy for symptomatic cholelithiasis, but rather as an opportunity to reconsider the indication when the a priori likelihood of achieving a pain-free state is low, surgical capacity is limited, and the burden of surgery is substantial. While the majority of surgically treated patients were operated on within 6 weeks, 26.3% of patients in the restrictive arm required no surgical treatment over a period of 5 years. 1 We agree that cholecystectomy is the definitive surgical solution for complicated cholecystolithiasis, but we argue that it is not the solution for all patients with abdominal pain in the presence of gallstones. The C-GALL trial reinforces that symptomatic cholecystolithiasis is not exclusively a surgical disease. 2 After 2 years of follow-up, only 25% of patients in the conservative arm required surgery. Importantly, at the end of followup, outcomes related to quality of life, abdominal pain, and biliary or surgical complications were similar between both groups. 2 Two recent randomized clinical trials clearly show that a restrictive strategy or even conservative management is safe and feasible, demonstrating that not all patients with symptomatic cholecystolithiasis require surgery. Irritable bowel syndrome and dyspepsia are common causes of persistent pain and should be excluded prior to surgery. 3 Second, the relationship between gallstones and metabolic syndrome highlights a broader, systemic issue that calls for a more holistic approach. Simply performing a cholecystectomy without addressing the underlying metabolic factors or functional disorders is short-sighted and can lead to suboptimal long-term outcomes. A more comprehensive management strategy, which considers lifestyle, dietary factors, and metabolic health, may be more effective in treating the root causes of symptomatic cholecystolithiasis and preventing other sequelae of metabolic syndrome.We acknowledge that it could be debated whether the Izbicki pain score, originally developed for pancreatitis, is the right instrument to evaluate persistent pain after surgery. However,
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.